Abstract. An aqueous extract of Ceylon cinnamon (C. zeylanicum) is found to inhibit tau aggregation and filament formation, hallmarks of Alzheimer's disease (AD). The extract can also promote complete disassembly of recombinant tau filaments and cause substantial alteration of the morphology of paired-helical filaments isolated from AD brain. Cinnamon extract (CE) was not deleterious to the normal cellular function of tau, namely the assembly of free tubulin into microtubules. An A-linked proanthocyanidin trimer molecule was purified from the extract and shown to contain a significant proportion of the inhibitory activity. Treatment with polyvinylpyrolidone effectively depleted all proanthocyanidins from the extract solution and removed the majority, but not all, of the inhibitory activity. The remainder inhibitory activity could be attributed to cinnamaldehyde. This work shows that compounds endogenous to cinnamon may be beneficial to AD themselves or may guide the discovery of other potential therapeutics if their mechanisms of action can be discerned.
INTRODUCTION
Extracellular plaques (amyloid-β; Aβ) and intracellular neurofibrillary tangles of tau are the hallmarks of Alzheimer's disease (AD) [1] . Recently, the belief has emerged that tangles are formed as a downstream event in relation to amyloid formation, and thus are possibly the central pathology of this neurodegenerative process [2] . This is consistent with the recent demonstration that immunization against Aβ 42 was effective in reducing amyloid plaque load in humans, but had no effect on improving cognitive function [3, 4] . In addition, the γ-secretase inhibitor Flurizan, a selective Aβ 42 -lowering agent, was shown in a recent Phase III clini-cal trial not to have significant effect on cognition and daily function in AD patients [5] [6] [7] . In contrast, two tau aggregation inhibitors have recently been reported to significantly attenuate the decline of cognitive function and disease progression in humans [8] [9] [10] . Thus, it is emerging that agents capable of preventing tau aggregation may be key in the development of new AD therapies. To date, however, drugs targeting tau have not yet been approved for clinical use. Rather, the few currently approved drugs aim to inhibit cholinesterase function or neurotoxicity, and most candidate drugs in human trials are aimed at inhibiting amyloid plaque formation or other targets [11] .
Cinnamon spice and its use as a condiment or flavoring has been known from antiquity. The term cinnamon correctly refers to the "true" cinnamon produced from the thin inner bark of the plant Cinnamomum verum (also known as Cinnamomum zeylanicum) from Sri Lanka, which produces 90% of the world's cinnamon today. However, related species corresponding to Chinese cinnamon, Vietnamese cinnamon, and Indonesian cinnamon are often labeled and commercialized as cinnamon. Cinnamon and its extract, irrespective of source, have been associated with a variety of health beneficial effects, including anti-microbial, anti-viral, antioxidant, and insulin-like activities. Many of the corresponding bioactivities are possibly attributed to cinnamaldehyde, a major constituent of the essential oil responsible for the flavor and aroma of whole cinnamon. In addition, a number of polymeric polyphenol molecules known as proanthocyanidins are present in the aqueous extract that are likely responsible for the majority of the antioxidant properties of cinnamon (see [12] ).
While the health-beneficial effects of bio-flavanoids in general are traditionally thought to be due to their antioxidant activity, proanthocyanidins exhibit other properties that may be important for their bioactivities. For example, it has been suggested that related polyphenols can inhibit formation of amyloid fibrils independent of oxidative conditions [13, 14] , and an alternate mechanism involving aromatic interactions of the polyphenol with Aβ has been proposed to explain inhibition [14] . A general feature described much earlier and relating to the bioactivity of proanthocyanidins is their high binding affinity to unstructured proteins particularly rich in proline, for example, salivary proteins or proteins such as collagen that have repeat structures involving proline residues [15] [16] [17] [18] [19] . Since tau is a protein that displays little to no structure under native conditions [20] , and the full-length molecule contains significant prolyl-rich regions, we investigated the effects of an aqueous extract of cinnamon containing proanthocyanidins on tau aggregation. We found that the extract from whole cinnamon effectively inhibited aggregation of human tau in vitro, and that the inhibitory activity could be attributed to both a proanthocyanidin trimer, and cinnamaldehyde.
MATERIALS AND METHODS

Materials
Ground cinnamon (Cinnamomum zeylanicum) was obtained from Penzeys Spices in Brookfield, WI. Chemicals needed for expression and purification of tau and experiments measuring tau aggregation were purchased largely from Sigma. Paired helical filaments (PHF) were a generous gift from P. Davies at the Albert Einstein college of Medicine.
Tau
expression and purification
The longest human isoform of tau (4RL) and residues 255-441 (Tau 187 ) of the 4RL isoform are amplified by PCR, cloned into pET28 vector and expressed in E. coli strain BL21DE3. Growth, expression and purification of the recombinant tau proteins follow a protocol used in this laboratory [21] .
Preparation of cinnamon extract
Five grams of finely ground C. zeylanicum was added to 50 ml of 40
• C nanopure water in a round bottom flask suspended in a mineral oil bath equilibrated to 40
• C and stirred rapidly for 10 min. The suspension was then centrifuged at 4
• C for 10 min at 12,000 g, after which the supernatant was placed in a pre-chilled beaker in an ice bath and stirred for 30 min. Some precipitate formed during this treatment and was removed by centrifugation. The supernatant was filtered through a 0.2 µm cellulose acetate membrane syringe filter, flash frozen in a dry ice/ethanol slurry, and lyophilized for 18 hr using the Labconco Freeze dry system Freezone 2.5. The resulting powder was weighed and found to represent approximately 7% of the starting material and stored in the dark at room temperature (RT). This powder re-dissolved in water is referred to as cinnamon extract (CE) throughout this study.
Tau
Aggregation
Aggregation of 50 µM recombinant Tau 187 in 20 mM sodium phosphate pH 6.9, 50 mM NaCl is initiated by the addition of 0.11 mg/mL Heparin (Sigma H3393). CE solid is weighed, resuspended in nanopure water, and applied to the reaction prior to heparin addition. Aggregation is monitored at 350 nm setting in a Shimadzu 1601 spectrophotometer equipped with a 8-microcell temperature controlled adaptor and UV probe software for up to 18 hr at RT.
SDS-PAGE
Samples are recovered from the spectrophotometer cuvette and treated with 1% N-Laurylsarcosine for 60 min at RT. Samples are then centrifuged in a Beckman OptimaMax tabletop ultracentrifuge in a TLA 100.3 rotor at 105,000 × g for 30 min at 22
• C. Supernatant is removed and the pellet is resuspended in the same volume, both treated with 1 × SDS loading buffer and placed on a 95
• C heat block for 10 min. Samples are analyzed by 12% SDS-PAGE.
Thioflavin S Fluorescence
Samples are diluted 30 fold in PBS pH 7.4 and incubated with 20 µM Thioflavin S for 45 min. Thioflavin S fluorescence is obtained by excitation at 440 nm in a SPEX Fluorolog 3 spectrofluorometer. The emission spectra are collected over a 490-550 nm range. The values at 510 are reported.
Transmission Electron Microscopy
After aggregation, 10 µM of sample is applied to a 300 mesh Formvar/carbon coated copper grid for 90 s, excess liquid in the sample is wicked using filter paper and stained with 10 µL of 1.5% uranyl acetate for 30 s, wicked again and washed with 10 µL of H20 for 90 s, wicked again and air dried. Samples are analyzed using a JOEL JEM-1230 transmission electron microscope.
Microtubule Assembly
Tubulin was isolated from bovine brain as described [22] . A working solution of whole CE (5 mg/ml) was prepared fresh daily. For microtubule assembly, purified tubulin (20 µM) was incubated in PEM buffer (100 mM Pipes, pH 6.8, 1 mM EGTA, 1 mM MgSO 4 , 2 mM GTP) in the presence or absence of tau 187 (5 µM) and/or CE (0.22 mg/ml). Assembly was carried out at 37
• C for 90 min, followed by centrifugation of the assembly mixtures through a 50% sucrose cushion at 150,000 x g for 12 min. The resulting supernatant and pellet fractions were assayed for tubulin concentration by Coomassie blue-stained 8% SDS-PAGE gel. The amount of tau-assembled tubulin in the presence and absence of CE was compared by an unpaired t test (N = 3).
Mass Spectrometry
Electrospray mass spectrometry (ESI-MS) and tandem mass spectrometry (MS/MS) experiments are performed on a Micromass QTOF2 tandem mass spectrometer system (Waters Corporation, Milford, MA) using a Harvard Apparatus syringe pump 22 (Harvard Bioscience, Holliston, MA) for sample infusion.
High Performance Liquid Chromatography
HPLC is done on a Waters 1525 Binary HPLC pump equipped with a Waters 2417 dual wavelength detector (Waters Corporation, Milford, MA) operated with Breeze software. The HPLC mobile phase consists of HPLC grade H 2 O/Acetonitrile with 0.1% trifluoroacetic acid (TFA). A Symmetry C18 analytical column (3.5 mm, 4.6 mm × 150 mm) (Waters Corporation, Milford, MA) is used for reverse phase separations.
Neuronal culture
Primary hippocampal cells were prepared from day 18 embryos of Sprague-Dawley rats obtained from Charles River. Briefly, the hippocampi were dissected out in HBSS (Gibco) buffered with HEPES, pH 7.3, and dissociated with trypsin-EDTA treatment. Cells were resupended in 10% MEM containing 20% glucose, 1 mM pyruvate, 1% penicillin and streptomycin and seeded in 24-well poly-L-lysine coated plates at a density of 1.25 × 10 5 cells/well. After 24 hr, half of the media was replaced with Neurobasal medium (Gibco) supplemented with 2% B-27 (Invitrogen), 0.5 mM L-glutamine, and 1% penicillin and streptomycin. After two days in culture, cytosine arabinofuranoside was added to minimize glial cell proliferation. The cells were cultured for 9-10 days to allow for maturation. Every fourth day, 50% of the culture volume was replaced with fresh medium.
RESULTS
Extract of Cinnamomum zeylanicum inhibits aggregation of tau
187
An aqueous extract from C. zeylanicum was prepared and tested for its ability to interact with tau using an in vitro tau aggregation assay. We employed an N-terminal truncation fragment of tau (residues 255-441, tau 187 ), which comprises the complete microtubule binding repeat region (4R) and the C-terminal tail of human tau. This construct aggregates on a faster time scale than does full-length tau, gives several fold greater amplitude of aggregation, and in our hands aggregates more consistently and reproducibly than does the full-length molecule [23] . Aggregation of tau 187 was monitored by a number of methods including solution turbidity, enhanced fluorescence emission from thioflavin T, electron microscopy, and centrifugation. Figure 1A shows the time course of tau aggregation measured by turbidity, which reveals sigmoidal kinetics typical of many amyloid aggregation systems. After 12 hr of aggregation, the extent of turbidity was reduced by approximately 75% in response to addition of CE (0.11 mg/ml). The extent of tau aggregation in the presence versus absence of CE was also determined by fluorescence emission from thioflavin S, an established reporter of fibril formation [24] . The results from both the turbidity and fluorescence measurements were found to be consistent with each other (Fig. 1A,B) . In addition, tau after aggregation was separately treated with sarkosyl to dissolve non-specific aggregates as opposed to bona fide tau filaments. After centrifugation for 1 hr at 105,000g, supernatants and pellets were analyzed by SDS gel electrophoresis (Fig. 1C) . The results show a decrease in protein in the pellet of tau treated with CE and an increase in tau in the soluble fraction, further suggesting that the extract specifically inhibits formation of bona fide fibers. Finally, analysis of the aggregates by electron microscropy revealed that tau in the control sample was present largely as fibers with dimensions of approximately 20 nm in width and up to 1 µm in length (Fig. 1D ) but in the presence of extract few to no fibers were formed (Fig. 1E) . Some smaller, undefined tau species were present. This residual speckled material in the electron micrographs was not observed in the absence of heparin, and thus possibly corresponds to nuclei of tau aggregates. Similar structures have been observed with aggregates of α-synuclein [25] .
Effect of CE on pre-formed tau filaments
Given that the extract can effectively inhibit the formation of tau fibers, it was of interest to test if the extract can promote disassembly of pre-formed tau fibers. Tau 187 was induced to undergo aggregation for 24 hr (Fig. 2B) at which time the resulting fibers were treated with either extract or water, followed by incubation for another 24 hr. While fibers continued to accumulate in the control sample with water ( Fig. 2D) , fibers that were treated with extract underwent significant disassembly over a 24 hr period (Fig. 2C) . The residual speckled material apparent after complete fiber disassembly (Fig. 2C ) was similar in appearance to the material that accumulated in response to inhibition of net aggregation (Fig. 1E) . This is consistent with the possi- bility that CE appears to promote formation of the same final oligomeric structure(s) starting either from the aggregation of monomeric tau or the disassembly of polymeric tau fibers. This suggests that the active molecules in CE might bind to a specific tau structure/oligomer and inhibit aggregation mechanistically, as opposed to inhibiting aggregation via some non-specific action.
Effect of CE on paired helical filaments from brain
We tested if whole CE could disassemble bona fide PHF tau filaments isolated from human brain. PHF from deceased AD patients were incubated in the absence (Fig. 3A,C) or presence (Fig. 3B,D) CE for three days. CE caused major disruption to the overall morphology of the PHF fibers. Significant debris was generated, and fibers became disorganized and exhibited a frayed appearance, suggestive of a partial unwinding or disassembly of the paired-helical structure. However, CE did not result in complete disassembly of PHFs even after prolonged incubation times. The effect of the extract on PHFs suggests that the inhibitory activity is not due to competition with heparin in the tau aggregation ( Fig. 1) and disassembly (Fig. 2) assays.
Effect of CE on aggregation of full-length tau
Although our experiments have shown that tau 187 aggregation could be effectively inhibited by CE, it was important to determine if inhibition on bona fide fulllength tau could be observed. To test this, we aggregated full-length tau (441 aa) for three days in the absence or presence of CE. Figure 4A shows that aggregation of tau F L without extract resulted in formation of classic PHF between 0.2 and 2 µm in length. In the presence of CE, however, filamentous tau was not observed (Fig. 4B) . To quantify the degree of inhibition, we measured fibrillar structures by thioflavin S reactivity in the presence versus absence of CE (Fig. 4C) . The qualitative data from EM and quantitative data from fluorescence were consistent with each other. These experiments show that the inhibitory effect of CE is not restricted to an engineered truncation fragment of tau (tau 187 ) but also acts on the bona fide full-length tau isoform.
Effect of CE on tubulin assembly
The effect of CE on microtubule assembly was tested to determine if the extract affects normal tau func- tion. Purified tubulin was incubated with CE, tau 187 or both, and microtubule assembly was monitored by centrifugation, and the soluble versus pelletable tubulin ratio was determined. Figure 5 shows that tau 187 could promote microtubule assembly from free tubulin as expected (cf. lanes 1&2 to 3&4). The extract does not significantly impede tubulin assembly based on the constant ratio of soluble versus insoluble tubulin (cf. lanes 3&4). CE alone (i.e., without tau 187 ) did not precipitate tubulin (cf. lanes 1&2). The integrity of the assembled microtubules was verified by transmission EM (not shown).
Identification of proanthocyanidin as an inhibitory component in CE
Proanthocyanindins are polyphenols derived from epicatechin or related flavonoids by covalent linkage forming oligomers of up to 9 to10 monomeric units or more [26, 27] . Extracts of cinnamon contain multiple proanthocyanindin species whose monomeric units are singly-or doubly-linked through C-C or C-O bonds, Fig. 5 . CE does not prevent tau-dependent microtubule assembly. MAP-free tubulin isolated from bovine brain was assembled at 37 • C at a 4:1 ratio of tubulin:tau 187 in the presence or absence of 0.22 mg/ml CE. Following assembly, tubulin polymer was isolated by centrifugation, and the resulting supernatant (S) and pellet (P) samples were analyzed by SDS PAGE. In the absence of tau 187 there is no tubulin assembly in either the absence (lanes 1) or presence (lanes 2) of CE. In the presence of tau 187 , significant tubulin assembly is observed in both the absence (lanes 3) and presence (lanes 4) of CE.
giving rise to the quinol (B-type) or quinone (A-type) redox forms, respectively. The ESI-mass spectrum of the solids obtained from the aqueous extract of C. zey- lanicum is shown in Fig. 6A . The mass/charge of the species shown is expected for a B linked dimer, an A linked trimer, and other oligomers with one A linkage and multiple B linkages. MS/MS fragmentation of the dimer, trimer, tetramer, and pentamer and analysis of their Diels-Alder cleavage products [28] provided conclusive evidence for the assignment of these linkages (results not shown).
We resolved whole CE by reverse phase HPLC (Fig. 6B) and identified a major peak that had the same retention time and molecular mass (865 Da. determined by mass-spectrometry, data not shown) as did a purified A-linked proanthocyanidin trimer standard from previous studies [29] (Fig. 6C) . This peak was isolated and tested for tau 187 aggregation inhibitory activity. Like whole CE, the purified trimer proved to be an effective inhibitor of tau 187 aggregation (Fig. 7) . However, compared to whole extract whose concentration was normalized for an equivalent amount of trimer (measured by HPLC peak area; see materials and methods), the inhibitory activity of the purified trimer appeared to be approximately 4-fold less. Thus the proanthocyanidin A-linked trimer is a major tau aggregation inhibitory component, but does not account for the entire inhibitory activity present in the whole extract.
Since the repeating unit of the proanthocyanidin trimer is epicatechin, we asked if epicatechin itself may be active in inhibiting tau aggregation. At concentrations similar to that of proanthocyanidin trimer, we did not observe inhibitory activity when pure epicatechin was tested in the tau aggregation (not shown). This implies that not all polyphenols are active, and since epicatechin is a strong antioxidant [30] , the inhibitory activity endogenous to CE and proanthocyanidin trimer cannot be attributable to their general antioxidant properties, the claim that links most dietary bio-flavanoids with their perceived health promoting activities.
Cinnamaldehyde displays tau aggregation inhibitory activity
Polyvinylpyrrolidone (PVP) is a structural analog of polyproline and is known to bind tightly and specifically to proanthocyanidins [31] . To determine if the inhibitory activity intrinsic to CE could be attributed to proanthocyanidins in general (dimers, trimers, tetramers, and higher order oligomers), we asked if the activity could be affinity-depleted by incubation of CE with PVP resin [32] . The supernatant after PVPdepletion was subject to mass spectrometry analysis, which revealed the complete absence of the proantho- cyanidins (not shown). However the same fraction retained as much as 20% of the overall inhibitory activity of the original extract.
HPLC analysis of the PVP-depleted supernatant revealed a major a peak that we identified as cinnamaldehyde, based on its retention time and molecular mass which were both identical to commercial trans-cinnamaldehyde (result not shown). We tested the effect of commercially available purified cinnamaldehyde for tau aggregation inhibitory activity, which revealed that under these conditions cinnamaldehyde could cause significant inhibition of tau aggregation in vitro (Fig. 8) . This supports the belief that the inhibitory activity in the extract after PVP-treatment is likely due to endogenous cinnamaldehyde.
Inhibition of tau aggregation is not associated with toxicity
Cellular toxicity associated with protein aggregation diseases has recently been attributed to the formation of soluble oligomers as opposed to insoluble amyloid fibrils [33, 34] . Toxicity associated with soluble oligomers of tau has previously been reported [35] , but to date the toxic structures have not been well characterized. We found that inhibition of tau aggregation by CE ( Figs 1E, 4B ), proanthocyanidin trimer (Fig. 7C) , or by cinnamaldehyde (Fig. 8C ) generated spherical structures visible by EM of average size (∼20 nm dia.) similar to those reported for toxic soluble oligomers of amyloid-β [35, 36] . We therefore tested if the products resulting from chemical inhibition of tau aggregation were toxic to neurons. We found that the reaction material after incubation of tau 187 with CE, trimer, or cinnamaldehyde under aggregation conditions was not toxic to hippocampal neurons in culture when applied at 2 and 5 µM tau 187 (Fig. 9 ). These concentrations were selected because it has previously been estimated that the concentration of tau inside a neuron is ∼2 µM [38, 39] , and essentially all of this is bound to the microtubular network [38, 40] . Furthermore, GomezRamos et al. [35] demonstrated tau toxicity using 5 µM tau applied extracellularly to SH-SY5Y cells. Thus, the spherical structures observed in Figs 1E, 4B, 7C and 8C do not appear to be toxic, which may further suggest that CE and molecules tested herein may not only inhibit fibril formation but in fact may inhibit cytotox- . Products resulting from inhibition of tau aggregation are not toxic to hippocampal neurons. Tau 187 (50 uM) was subjected to aggregation conditions by addition of heparin (0.11 mg/ml) for 24 hr in the presence of trimer (200 µM), cinnamaldehyde (100 µM), or CE (0.2 mg/ml). Embryonic day 18 (E18) rat primary hippocampal neurons cultured for 10 days in vitro were then treated with the inhibited reaction material at tau 187 concentrations equal to 2 and 5 µM final. Cell viability after 12 hr incubation was determined by an MTT assay.
icity. Precedence for this has been shown for the green tea compound EGCG, which inhibits aggregation of α-synuclein and Aβ in vitro by generating off-pathway oligomers that are non-toxic [25] .
DISCUSSION
The aggregation of tau into neurofibrillary tangles is a hallmark of AD. While a mechanistic link between tau aggregation and neuropathology has not been demonstrated, recent studies suggest that specific inhibition of tau aggregation is a valid strategy for disease intervention [8] [9] [10] 41] . Given this, small molecule inhibitors of tau aggregation have previously been sought [42] [43] [44] [45] including the identification of several compounds from a combinatorial library screen [46] .
There is currently heightened awareness of plantderived extracts and bio-flavanoids being touted as general health-beneficial food supplements. The term "functional food" has been used to refer to natural or formulated food that is active in preventing or treating a particular disease [47] . Herein we have shown that an aqueous extract of Ceylon cinnamon (C. zeylanicum) can inhibit the aggregation of human tau in vitro, a key process in AD. The extract of cinnamon does not inhibit the normal function of tau in vitro, namely the regulation of microtubule assembly and dynamics, and neither whole ground cinnamon nor CE is toxic to humans [12] .
Fractionation of whole CE by reverse phase HPLC revealed two major peaks both that displayed inhibitory activity towards tau aggregation. These corresponded to an A-linked proanthocyanidin trimer species and cinnamaldehyde. Proanthocyanidins possess both chemical and physical characteristics important for their numerous effects in biological systems. For example, they can serve as antioxidants [29] , chelate metal ions [48] , and bind to proteins affecting their structure and solubility. Detailed physical studies using predominantly NMR spectroscopy have shown that polyphenols can bind to the main chain of peptides through hydrogen bonding and hydrophobic interactions, e.g., with the carbonyl group of a prolyl linkage or by their interactions with the prolyl ring. No covalent interactions or change of secondary structure have been demonstrated with non-oxidized polyphenols but evidence suggests that its interactions with a human salivary protein fragment can likely influence conformational dynamics [49] . The proanthocyanidin trimer that we have identified appears identical to an A-linked trimer [29] , previously isolated also from cinnamon that exhibits insulin-mimetic activity in cultured adipose cells [50] . While a link between diabetes and an increased incidence of AD appears to be strengthening [51, 52] , it is unclear how the apparent dual activities of the trimer relate to this growing connection.
The relationship between proanthocyanidinstructure and tau aggregation inhibitory activity is unclear from available data. Two main types of proanthocyanindins exist, the oxidized A-type that involves double linkage of flavan units 1 and 2 ( Fig. 6 ) through C-C and C-O-C bonds, and the reduced B-type involving linkage through a single C-C bond. In addition, each flavan unit has two chiral centers allowing for 4 possible stereoisomers, although the most commonly occurring is the 2R,3R stereoisomer referred to as (−) epicatechin [27] . Taniguchi et al. [44] and Masuda et al. [45] tested the inhibitory effects of a number of polyphenolic compounds on tau aggregation and also found that catechin and epicatechin were ineffective. However, the 3-gallate derivative of epicatechin was a potent inhibitor of tau aggregation. In the same study, procyanidin B2 dimer (2R,3R) was also reported to be ineffective, but procyanidin B1 dimer (2R,3S) displayed good inhibitory activity. Thus, flavan oligomerization, stereochemistry, and specific chemical modification all can influence the structure-activity relationships. On the other hand, the role of A-versus B-type linkage has not been directly tested. We have not yet identified the stereochemical structure of the B-linked dimer endogenous to CE, nor have we been able to isolate and test the potential inhibitory activity of the dimer or other endogenous proanthocyanidins.
The precise tau species targeted by the inhibitory molecules in CE have not been identified. Consequently the mechanism by which inhibition of aggregation and fiber disassembly occurs is similarly unknown. Inhibition of aggregation could occur by binding to and trapping either the tau monomer or an oligomer, thereby preventing net elongation while still allowing net disassembly. It also appears that fibers themselves can be directly targeted by the trimer as seen by the effect that CE or proanthocyanidin trimer has on PHF morphology. The fact that we do not observe net disassembly in the case of PHFs is likely due to the greater stability of endogenous fibers from brain as a function of their age [53] . This does not detract from the potential of CE as a possible therapeutic, because it would still be expected to inhibit net aggregation in neurons.
Although our studies invoke the possibility of using CE as a potential therapy, all studies herein have been performed in vitro. A next important consideration is the bioavailability and metabolism of the trimer and cinnamaldehyde. On one hand, most studies suggest that polymers of catechin or epicatechin are not bioavailable [54] [55] [56] [57] [58] . On the other, procyanidins ranging from dimers up to pentamers have been shown to be bioavailable in rats [59, 60] , and dimers and trimers have been reported to be bioavailable in humans [61, 62] . Thus the bioavailability of proanthocyanidin poly-mers remains inconclusive. Cinnamaldehyde is more bioavailable than proanthocyanindins but has a short half-life [63] [64] [65] . There are almost no studies that address the permeability of either of these molecules to the brain, although the related anthocyanins have been reported to be brain permeable [66] . There is evidence that 14 C-labeled polyphenols from grapes containing proanthocyanidins (H. Kim, personal communication) can pass the blood brain barrier [67] . In this case, what compounds actually are transported have not been determined. Regardless, the in vitro work herein has set the stage for animal studies. In parallel, investigating the mechanism of inhibition of tau aggregation by proanthocyanidins and cinnamaldehyde may guide the development of second generation compounds that may have greater potential for the clinic.
